Biotricity, Inc.
BTCY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4 | $4 | $4 | $4 |
| % Growth | 0.3% | 4.6% | 2.3% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 81.9% | 80.5% | 80.4% | 76.4% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $4 | $3 |
| Operating Income | $0 | $0 | -$1 | -$0 |
| % Margin | 7% | 7.3% | -23.1% | -4.7% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$1 | -$1 | -$2 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$2 | -$1 |
| % Margin | -17.8% | -17.3% | -52.3% | -34% |
| EPS | -0.026 | -0.029 | -0.088 | -0.054 |
| % Growth | 8.4% | 67.5% | -62.5% | – |
| EPS Diluted | -0.026 | -0.029 | -0.088 | -0.054 |
| Weighted Avg Shares Out | 26 | 26 | 23 | 24 |
| Weighted Avg Shares Out Dil | 26 | 26 | 23 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | -$1 | -$0 |
| % Margin | 9.6% | 8.6% | -23.7% | -2.4% |